Accessibility settings

This paper is in the following e-collection/theme issue:

Non-randomized Protocols and Methods (ehealth) (725) mHealth for Symptom and Disease Monitoring, Chronic Disease Management (1815) Diabetic Retinopathy (20) Ophthalmology (80) Telehealth and Telemonitoring (2210) Ophthalmology (80) Diabetic Retinopathy (20) mHealth for Symptom and Disease Monitoring, Chronic Disease Management (1815) mHealth for Treatment Adherence (497) Telehealth and Telemonitoring (2210)

Published on in Vol 15 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/85764, first published .
Remote Management of Patients With Diabetic Macular Edema Receiving Long-Term Intravitreal Anti–Vascular Endothelial Growth Factor Therapy (RE-SHINE Study): Protocol for a Real-World Study

Remote Management of Patients With Diabetic Macular Edema Receiving Long-Term Intravitreal Anti–Vascular Endothelial Growth Factor Therapy (RE-SHINE Study): Protocol for a Real-World Study

Remote Management of Patients With Diabetic Macular Edema Receiving Long-Term Intravitreal Anti–Vascular Endothelial Growth Factor Therapy (RE-SHINE Study): Protocol for a Real-World Study

Authors of this article:

Shu Li1, 2 Author Orcid Image ;   Yupeng Xu2, 3 Author Orcid Image ;   Yan Xu2, 3 Author Orcid Image ;   Xun Xu2, 3 Author Orcid Image
Article Authors Cited by Tweetations Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.